STOCK TITAN

Delphx Cap Mkts Stock Price, News & Analysis

DPXCF OTC

Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.

DelphX Capital Markets Inc. (DPXCF) provides advanced structured products for fixed income market participants, specializing in credit risk mitigation through instruments like collateralized put options and reference notes. This page serves as the definitive source for official company announcements and market-relevant updates.

Access real-time press releases covering strategic partnerships, product innovations, and financial performance. Investors will find critical updates on securities offerings, regulatory developments, and operational milestones that impact credit risk management strategies.

Our curated news collection enables institutional clients and analysts to track DelphX's progress in developing collateralized solutions while monitoring key initiatives through Quantem LLC subsidiary. Content spans earnings disclosures, technology implementations, and market expansion efforts.

Bookmark this resource to maintain awareness of DelphX's evolving role in creating transparent risk transfer mechanisms for fixed income dealers. Regular updates ensure you stay informed about developments affecting credit rating security products and related financial instruments.

Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced significant achievements in 2024 and outlined its growth strategy for 2025. The company is preparing to execute its first commercial transactions in Q1 2025, involving downgrade protection coverage on a $3 billion notional value bond portfolio.

The company's Credit Rating Securities (CRS) program has received positive feedback from hedge funds and institutional buyers, with active term sheets already exchanged between parties. This innovative platform enables insurance companies, hedge funds, and institutional investors to manage downgrade risks while generating new returns.

CEO Patrick Wood emphasized that DelphX is delivering the most significant innovation in fixed income markets in over a decade, with the company positioned for increased CRS adoption and positive cash flows in 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed its previously announced non-brokered private placement, raising C$348,100 through the issuance of 2,900,834 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant, exercisable at C$0.20 for five years.

Insiders participated by subscribing for 420,000 units. AlphaNorth Asset Management will receive C$3,528 in finder's fees and 29,400 finders' warrants. The offering, conditionally accepted by TSX Venture Exchange, includes a four-month plus one day hold period for issued securities. Proceeds will be used for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
private placement
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant. The shares, valued at C$60,000, are being issued as payment for services related to the Company's Credit Rating Security (CRS) product, including refinement of pricing models, preparation of presentations, and assistance with broker dealer negotiations. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 182,102,033 common shares outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.28%
Tags
none
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announced it will issue 138,888 common shares to a consultant as payment for services related to securing a non-binding letter of intent with hedge funds for up to $3 billion of notional credit spread protection through their CRS program. The shares will be issued at $0.18 per share, totaling C$25,000. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 181,812,350 common shares outstanding. The shares will be issued as restricted securities under U.S. Securities Act exemptions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces a non-brokered private placement to raise C$348,100 through the issuance of 2,900,833 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant exercisable at C$0.20 for five years. The company will pay cash finder's fees and issue finders' warrants to eligible finders. The offering requires TSX Venture Exchange approval and includes a four-month plus one-day hold period. Proceeds will be used for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.67%
Tags
private placement
-
News
Rhea-AI Summary

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces plans to seek TSX Venture Exchange approval to extend the exercise period of 5,422,221 share purchase warrants by one year to December 7, 2025. The warrants, originally issued in a December 2022 private placement, are exercisable at $0.15 per common share. Of these warrants, 1,611,111 are held by related parties, constituting a related party transaction. The transaction is exempt from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.67%
Tags
none
News
Rhea-AI Summary

DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,650,000 stock options to eligible participants under its stock option plan. The Board of Directors approved this grant with the following terms:

  • Two-year maturity
  • Exercise price of $0.25 per common share
  • Options are exercisable for common shares of DelphX

This decision aligns with the company's stock option plan and may be seen as a strategy to incentivize and retain key personnel or partners.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced a non-binding letter of intent with multiple hedge funds to offer up to $3 billion of notional credit spread protection through its Credit Rating Securities (CRS) program. The agreement, dated August 27, 2024, is subject to conditions including DelphX facilitating bond portfolios for credit spread protection and final tax review. The company reports positive interest from potential buyers of protection, as CRS offers a new risk management tool for insurance companies and others seeking downgrade risk mitigation. DelphX will continue to update on the CRS program's progress.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary

DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,200,000 stock options to eligible participants. The options, approved by the company's Board of Directors, have a two-year maturity and can be exercised at $0.25 per common share. This grant is part of DelphX's stock option plan and aims to align the interests of participants with those of shareholders, potentially incentivizing performance and retention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has successfully closed its over-subscribed non-brokered private placement, raising C$539,000 by issuing 4,491,666 units at C$0.12 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at C$0.25 for five years. Insiders participated in the offering, subscribing for 666,666 units. The company will pay cash finder's fees totaling C$37,730 and issue 314,417 finders' warrants to eligible finders. The offering is subject to final TSX Venture Exchange approval, with securities having a four-month plus one-day hold period. DelphX plans to use the net proceeds for general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.55%
Tags
private placement

FAQ

What is the current stock price of Delphx Cap Mkts (DPXCF)?

The current stock price of Delphx Cap Mkts (DPXCF) is $0.06 as of April 29, 2025.

What is the market cap of Delphx Cap Mkts (DPXCF)?

The market cap of Delphx Cap Mkts (DPXCF) is approximately 11.0M.
Delphx Cap Mkts

OTC:DPXCF

DPXCF Rankings

DPXCF Stock Data

10.97M
139.01M
31.07%
14.28%
Capital Markets
Financial Services
Link
Canada
Toronto